Image
![South Central AETC logo graphic image](/sites/default/files/styles/content_tiny/public/resources/AETC-S-Central-graphic-ID-outline-01_17.png?itok=h4rR9_N6)
Training slides review the impact of SVR and the risk of diabetes in patients treated with DAAs for hepatitis C virus (HCV) compared to untreated patients, and discuss the impact of SVR on liver complications including hepatocellular carcinoma in patients with HCV.
Browse more